Resources

Jane Wall discusses investment in Alchemab Therapeutics, Life Sciences Sector Plan: one year on, regulatory and trade links, Women in Biotech and BIA members lounge

Chris Molloy on scale-up policy, improving treatments pipeline, LSSP, GMM regulation, LLSW, MDUK's Pedal Paddle Peak and Dr Sally Ann Forsyth OBE

Key takeaways as another BIA Summer Party 2026 delivers for the life sciences sector

Myricx Bio reached agreement to be acquired by Novartis for up to $1.5 billion.

Brandon Capital announced the successful exit of its portfolio company Myricx Bio.

The UK’s innovative life sciences sector has called on Government to deliver policy continuity, unlock scale-up investment and improve patient access to new medicines.

Innovation Orbit 2026 is FI Group by EPSA’s international guide to grants, R&D tax credits and public incentives for businesses planning R&D, CAPEX, digital transformation or decarbonisation projects.

BIO Convention, RQ Bio’s oversubscribed Series A, BIA Summer Party, expanding overseas webinar and BIA BD vacancy

With $47 million in seed funding now secured, TRIMTECH Therapeutics is accelerating development of its TRIMTAC and TRIMGLUE portfolio — a novel approach to eliminating disease-causing proteins.

A pipeline of encouraging funding opportunities for the engineering biology community

The challenges businesses must address to mitigate risk and ensure seamless compliance

New AI infrastructure, the MHRA AI Sandbox, life science leadership, global advocacy and BIA’s upcoming events

Pelago Bioscience has acquired RG Discovery. As a result of this acquisition, the largest Scandinavian CRO specializing in drug discovery has been created.

How finance leaders can manage R&D tax risk while supporting innovation investment

Grant awarded through the Parkinson's Disease Therapeutics Pipeline Program to support advancement of Harness' new programme targeting GCase and LIMP2 for Parkinson's disease.

Each month, our Policy and Public Affairs team will showcase how we are championing members’ voices in Government and Parliament.

BIA members gathered in London on Tuesday for our 26th annual Parliament Day

IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53 million.

Chris Molloy on Parliament Day, the EU start-up fund, MHRA rare disease regulation, Northern Ireland, women in biotech and scientific leadership